company background image
SVS

Solarvest BioEnergyTSXV:SVS Stock Report

Market Cap

CA$7.2m

7D

-16.1%

1Y

44.4%

Updated

28 Nov, 2021

Data

Company Financials
SVS fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

SVS Stock Overview

Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products in Canada and internationally.

Price History & Performance

Summary of all time highs, changes and price drops for Solarvest BioEnergy
Historical stock prices
Current Share PriceCA$0.13
52 Week HighCA$0.55
52 Week LowCA$0.08
Beta0.76
1 Month Change-27.78%
3 Month Change-48.00%
1 Year Change44.44%
3 Year Change-38.10%
5 Year Change-51.85%
Change since IPO-62.86%

Recent News & Updates

Shareholder Returns

SVSCA Personal ProductsCA Market
7D-16.1%-3.0%-1.7%
1Y44.4%-6.7%21.9%

Return vs Industry: SVS exceeded the Canadian Personal Products industry which returned -6.9% over the past year.

Return vs Market: SVS exceeded the Canadian Market which returned 22.1% over the past year.

Price Volatility

Is SVS's price volatile compared to industry and market?
SVS volatility
SVS Average Weekly Movement15.2%
Personal Products Industry Average Movement12.7%
Market Average Movement9.4%
10% most volatile stocks in CA Market17.1%
10% least volatile stocks in CA Market3.5%

Stable Share Price: SVS is more volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 15% a week.

Volatility Over Time: SVS's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Canadian stocks.

About the Company

FoundedEmployeesCEOWebsite
2005n/aGerri Greenhamhttps://www.solarvest.ca

Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products in Canada and internationally. Its algal-based production systems are used to produce organic omega nutraceuticals and bio-pharmaceutical active ingredients/therapies. The company develops algae strains for the food enhancement and nutraceutical markets; and producing therapeutic proteins.

Solarvest BioEnergy Fundamentals Summary

How do Solarvest BioEnergy's earnings and revenue compare to its market cap?
SVS fundamental statistics
Market CapCA$7.19m
Earnings (TTM)-CA$3.46m
Revenue (TTM)CA$8.18k

928.6x

P/S Ratio

-2.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SVS income statement (TTM)
RevenueCA$8.18k
Cost of RevenueCA$42.73k
Gross Profit-CA$34.55k
ExpensesCA$3.43m
Earnings-CA$3.46m

Last Reported Earnings

Jul 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.063
Gross Margin-422.23%
Net Profit Margin-42,282.82%
Debt/Equity Ratio-159.5%

How did SVS perform over the long term?

See historical performance and comparison

Valuation

Is Solarvest BioEnergy undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Solarvest BioEnergy is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Solarvest BioEnergy has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Future Growth

How is Solarvest BioEnergy forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

15.3%

Forecasted Household industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Solarvest BioEnergy has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Solarvest BioEnergy performed over the past 5 years?

-19.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: SVS is currently unprofitable.

Growing Profit Margin: SVS is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: SVS is unprofitable, and losses have increased over the past 5 years at a rate of 19.4% per year.

Accelerating Growth: Unable to compare SVS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SVS is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (50.2%).


Return on Equity

High ROE: SVS's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Financial Health

How is Solarvest BioEnergy's financial position?


Financial Position Analysis

Short Term Liabilities: SVS has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: SVS has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: SVS has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: SVS's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SVS has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: SVS has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18.2% each year


Dividend

What is Solarvest BioEnergy current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate SVS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SVS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SVS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SVS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SVS's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

7.3yrs

Average management tenure


CEO

Gerri Greenham (70 yo)

12.5yrs

Tenure

Mr. Gerri J. Greenham is a Co-Founder of Phycobiologics Inc. and serves as its President. Mr. Greenham has been the Chief Executive Officer and President of Solarvest BioEnergy Inc. since May 4, 2009. He i...


Leadership Team

Experienced Management: SVS's management team is seasoned and experienced (7.3 years average tenure).


Board Members

Experienced Board: SVS's board of directors are seasoned and experienced ( 12.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 27.8%.


Top Shareholders

Company Information

Solarvest BioEnergy Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Solarvest BioEnergy Inc.
  • Ticker: SVS
  • Exchange: TSXV
  • Founded: 2005
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: CA$7.194m
  • Shares outstanding: 55.34m
  • Website: https://www.solarvest.ca

Location

  • Solarvest BioEnergy Inc.
  • 439 Helmcken Street
  • Yaletown
  • Vancouver
  • British Columbia
  • V6B 2E6
  • Canada

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/11/28 23:24
End of Day Share Price2021/11/26 00:00
Earnings2021/07/31
Annual Earnings2021/07/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.